Accelovance has named Stephan A. Bart Sr., M.D. chief medical officer. Bart will be responsible for medical affairs and site operations, focused on enhancing the level of clinical solutions Accelovance can provide to clients.
Most recently, Bart held a similar role at Idis and at SNBL Clinical Pharmacology Center. Bart has developed and managed teams for quality assurance, medical information, medical affairs, regulatory compliance and study management.
"We are excited to have Dr. Bart join our team in this role with his wealth of operational and medical knowledge. His background in private practice, site management organizations, phase I units and CROs align well with Accelovance's comprehensive service offering. He will support Accelovance's mission to bring greater value to a growing customer base while also strengthening our traditional and innovative services," remarked Steve Trevisan, president and CEO of Accelovance.